Sharon Tetlow
CIK: 0001328565
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GPCR
Structure Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
About TETLOW SHARON
TETLOW SHARON (SEC CIK 0001328565) files insider reports with the SEC as Director of Structure Therapeutics Inc. (GPCR).
Signal8 holds 2 ownership filings by TETLOW SHARON, all Form 4s, filed between Jun 25, 2025 and Jun 18, 2026. Those filings report 2 transactions, from Jun 23, 2025 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on TETLOW SHARON's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by TETLOW SHARON
Other insiders filing for Structure Therapeutics Inc. (GPCR)
- Coll Crespo Blas, CHIEF MEDICAL OFFICER
- Lin Xichen, CHIEF SCIENTIFIC OFFICER
- Berrios John Joseph, Chief Commercial Officer
- FMR LLC, 10% Owner
- Russell Angus C., Director
- LOVE TED W, Director